1. Home
  2. ICG vs ATYR Comparison

ICG vs ATYR Comparison

Compare ICG & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$0.99

Market Cap

49.4M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.53

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICG
ATYR
Founded
2017
2005
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.4M
49.2M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
ICG
ATYR
Price
$0.99
$0.53
Analyst Decision
Strong Buy
Hold
Analyst Count
2
9
Target Price
$5.25
$3.67
AVG Volume (30 Days)
146.9K
628.9K
Earning Date
05-21-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.98
EPS
N/A
N/A
Revenue
N/A
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.40
52 Week High
$2.28
$6.50

Technical Indicators

Market Signals
Indicator
ICG
ATYR
Relative Strength Index (RSI) 61.36 49.46
Support Level $0.93 $0.46
Resistance Level $1.02 $0.60
Average True Range (ATR) 0.09 0.04
MACD 0.01 -0.00
Stochastic Oscillator 91.79 25.09

Price Performance

Historical Comparison
ICG
ATYR

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: